Express Scripts says costly new cholesterol drugs could 'wreak havoc'

(Reuters) - Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent, newly approved cholesterol drugs could "wreak financial havoc" among its clients.